Video

Dr. Partridge on the Role of Genomic Testing in Breast Cancer

Ann H. Partridge, MD, MPH, discusses the role of genomic testing in breast cancer.

Ann H. Partridge, MD, MPH, vice chair of medical oncology, ​founder and director, Program for Young Women With Breast Cancer, director, Adult Survivorship Program, senior physician, Dana-Farber Cancer Institute, professor of medicine, Harvard Medical School, discusses the role of genomic testing in breast cancer.

Genomic expression prediction assays have been instrumental in understanding the value of chemotherapy ​for patient​s with breast cancer, says Partridge. ​For example, the Oncotype DX test looks at a set of 21 genes in cancer cells from tumor biopsy or surgery sample in order to obtain a recurrence score.

​Moreover, the test provides critical insight into whether a patient may or may not benefit from chemotherapy, Partridge explains.

Now, encouraging prospective data show that chemotherapy may be beneficial in the adjuvant setting for patients with node-negative or hormone receptor–positive breast cancer, concludes Partridge.

Related Videos
David A. Braun, MD, PhD
Bradley McGregor, MD,
Francisco J. Hernandez-Ilizaliturri, MD, professor, oncology, Department of Medicine – Lymphoma, director, Lymphoma Research, head, Lymphoma Translational Research Lab, associate professor, Department of Immunology, Roswell Park Comprehensive Cancer Center; clinical professor, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Rahul Banerjee, MD, FACP, assistant professor, Clinical Research Division, Fred Hutchinson Cancer Center; assistant professor, Division of Hematology and Oncology, University of Washington
Monica H. Vetter, MD
Ian Krop MD, PhD
Marco Davila, MD, PhD
Yvonne Mowery, MD, PhD, associate professor, Department of Radiation Oncology, UPMC Hillman Cancer Center/University of Pittsburgh, radiation oncologist, Mary Hillman Jennings Radiation Oncology, UPMC Shadyside
2 experts are featured in this series.
2 experts are featured in this series.